Multiple independent work reported that SHP2 regulates the maintenance of CSCs in various tissues [30, 63, 66–68], and the enrichment of stemness is often related to drug resistance of lung cancer [69, 70]. This evidence concerns the gene PTPN11 and lung carcinoma.